30 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... TreatmentInvasive ... eye Infectious Diseases ... #management #pharmacology ... #IDSA
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... patients with Lyme disease ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... #Regimens #IDSA
Invasive fungal infections: Morphology, Risk Factors, Disease Characteristics, Diagnostic Tools, First-Line Treatment
Aspergillus, Mucorales, P. Jiroveci, Cryptococcus,
Invasive fungal ... Risk Factors, Disease ... Tools, First-Line Treatment ... Fungal #Infections #InfectousDiseases ... #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment ... #management #opportunistic
Invasive Candidiasis (IC)

Diagnosis:
Culture:
 • Gold standard, but Slow (~2-3 days), 50% sensitivity
 • Blood Sample
 •
Invasive Candidiasis ... Line Targeted Treatment ... • Infectious Diseases ... #candida #auris ... #treatment
Listeriosis Summary - Listeria Monocytogenes
Pathogen: Listeria Monocytogenes - Gram-positive rod, Aerobic, facultative anaerobe, motile, beta-hemolytic, Non-spore-forming
Risk
disease • Pregnancy ... disease) • CSF ... Monocytogenes #diagnosis #management ... #infectiousdiseases ... #treatment #microbiology
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... Susceptibilities, Negative ... #candida #candidiasis ... #treatment #fungal
Listeriosis Summary - Listeria Monocytogenes
Pathogen: Listeria Monocytogenes - Gram-positive rod, Aerobic, facultative anaerobe, motile, beta-hemolytic, Non-spore-forming
Risk
disease • Pregnancy ... disease) • CSF ... Monocytogenes #diagnosis #management ... #infectiousdiseases ... #treatment #microbiology
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... patients with Lyme disease ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... #Candidiasis #candida ... #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic